Status:

TERMINATED

Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa

Lead Sponsor:

Centre Hospitalier Universitaire de Saint Etienne

Conditions:

Anorexia Nervosa

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Approximately 20% of anorexia nervosa cases do not respond to conventional management strategies: cognitive behavioral therapy, weight gain contract, drug treatments, etc ... - whether they are applie...

Eligibility Criteria

Inclusion

  • Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 anorexia nervosa criteria
  • Body Mass Index (BMI) \< 17kg/m2
  • Conventional treatment failure over the last 12 months
  • Refusal or no indication of artificial nutrition

Exclusion

  • Artificial nutrition
  • Other chronic diseases
  • drug use (except tobacco)
  • pregnancy
  • Edinburgh score \< 14

Key Trial Info

Start Date :

October 21 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 13 2022

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT03813355

Start Date

October 21 2020

End Date

July 13 2022

Last Update

April 6 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

CHU Clermont-Ferrand

Clermont-Ferrand, France

2

CHU Grenoble

Grenoble, France

3

Hospices Civils de Lyon

Lyon, France

4

CHU Saint-Etienne

Saint-Etienne, France, 42055

Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa | DecenTrialz